Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
President Donald Trump has consistently demonstrated a preference for maintaining control over escalation rather than allowing events to dictate American strategy.
The typical American citizen is today probably more likely to be killed by a home-grown extremist shooting up a school classroom, than by a religious zealot-turned-kamikaze pilot.